InflaRx N.V. revenue for the last year amounted to 207.04 k USD, the most of which — 179.33 k USD — came from its highest performing source at the moment, Novel Therapeutic Products, the year earlier bringing 68.21 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought InflaRx N.V. 179.33 k USD, and the year before that — 68.21 k USD.